| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (meticillin-resistant) |
>4 |
>4 |
≤0.12 － >4 |
Levofloxacin (Levaquin, Quixin)  |
1130 |
| Staphylococcus aureus (meticillin-resistant) |
>4 |
>4 |
0.25 － >4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1130 |
| Staphylococcus aureus (meticillin-resistant) |
16 |
>32 |
0.25 － >32 |
Levofloxacin (Levaquin, Quixin) |
1598 |
| Staphylococcus aureus (meticillin-resistant) |
- |
- |
0.06 － 2 |
Daptomycin (Cubicin) |
1261 |
| Staphylococcus aureus (meticillin-resistant) |
- |
- |
0.25 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
1261 |
| Staphylococcus aureus (meticillin-resistant) |
- |
- |
>100 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1602 |
| Staphylococcus aureus (meticillin-resistant) |
- |
- |
>100 － ? |
Streptomycin |
1602 |
| Staphylococcus aureus (meticillin-susceptible) |
0.06 |
0.12 |
0.03 － >16 |
Solithromycin (CEM-101 and OP-1068) |
1130 |
| Staphylococcus aureus (meticillin-susceptible) |
≤0.12 |
≤0.12 |
≤0.12 － >4 |
Clindamycin (Cleocin) |
1130 |
| Staphylococcus aureus (meticillin-susceptible) |
0.12 |
0.25 |
0.06 － >16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
1130 |
| Staphylococcus aureus (meticillin-susceptible) |
≤0.25 |
≤0.25 |
≤0.25 － >4 |
Trimethoprim/Sulfamethoxazole |
1130 |
| Staphylococcus aureus (meticillin-susceptible) |
0.25 |
0.5 |
≤0.12 － >4 |
Levofloxacin (Levaquin, Quixin) |
1130 |
| Staphylococcus aureus (meticillin-susceptible) |
0.5 |
0.5 |
0.25 － 1 |
Quinupristin/Dalfopristin (Synercid) |
1130 |
| Staphylococcus aureus (meticillin-susceptible) |
>0.5 |
>4 |
0.25 － >4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1130 |
| Staphylococcus aureus (meticillin-susceptible) |
2 |
2 |
1 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1130 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
0.039 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1044 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
0.047 |
? － ? |
Gemifloxacin |
1044 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
0.1 |
? － ? |
Gatifloxacin (Tequin) |
1044 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
0.25 |
? － ? |
Cloxacillin (Tegopen, Coxapen) |
1044 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
0.25 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
1044 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
0.25 |
? － ? |
Ofloxacin (Floxin) |
1044 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
0.31 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1044 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
1 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1044 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
2 |
? － ? |
Cefazolin (Ancef, Kefzol, Zolicef) |
1044 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
- |
0.03 － 2 |
Daptomycin (Cubicin) |
1261 |
| Staphylococcus aureus (meticillin-susceptible) |
- |
- |
0.25 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
1261 |
| Staphylococcus aureus (MGH 10 + methicillin-resistant) |
- |
- |
0.5 － ? |
Telavancin (TD-6424, Vibativ) |
269 |
| Staphylococcus aureus (MGH 10 + methicillin-resistant) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
269 |